7906
Y. Ueno et al. / Tetrahedron 56 (2000) 7903±7907
7.49 (s, 1H), 7.36±6.79 (m, 13H), 6.22 (t, J6.6 Hz, 1H),
5.74 (m, 1H), 5.30 (m, 2H), 4.55 (dd, J6.4, 4.6 Hz, 1H),
3.76 (s, 6H), 3.35 (m, 1H), 3.30 (d, J10.3 Hz, 1H), 3.17
(m, 1H), 3.09 (d, J10.3 Hz, 1H), 2.22 (m, 2H), 2.03 (t,
J7.6 Hz, 2H), 1.96 (m, 4H), 1.84 (d, J7.3, 14.7 Hz, 1H),
1.58 (m, 3H), 1.51 (m, 2H), 1.44 (s, 3H), 1.23 (m, 18H), 0.84
(t, J7.3 Hz, 3H), 0.81 (s, 9H), 0.04 (s, 3H), 20.06 (s, 3H).
HRMS (FAB) calcd for C57H83O8N3SiNa (MNa1):
988.5847. Found: 988.5836. Anal. Calcd for
C57H83O8N3Si: C, 70.84; H, 8.66; N, 4.35. Found: C,
70.60; H, 8.74; N, 4.24.
50-O-(Dimethoxytrityl)-40-C-[N-(cholesteryloxycarbonyl)-
aminoethyl]thymidine (8c). Compound 7c (141 mg,
0.13 mmol) was de-silylated as described in the preparation
of 8a to give 8c (95 mg, 75% as a white foam): FAB-MS m/z
1
1000 (MH1); H NMR (400 MHz, CDCl3) d 8.31 (s, 1H),
7.52 (s, 1H), 7.40±6.83 (m, 13H), 6.34 (t, J6.6 Hz, 1H),
5.36 (m, 1H), 4.92 (t, J5.6 Hz, 1H), 4.51 (m, 1H), 4.45 (m,
1H), 3.79 (s, 6H), 3.24 (m, 3H), 3.11 (m, 2H), 2.39 (m, 2H),
1.93 (m, 2H), 2.24±0.67 (m, 44H). HRMS (FAB) calcd for
C61H82O9N3 (MH1): 1000.6051. Found: 1000.6060.
50-O-(Dimethoxytrityl)-40-C-[N-(palmitoyl)aminoethyl]-
30-O-(succinyl)thymidine (9a). A mixture of 8a (57 mg,
69 mmol), succinic anhydride (21 mg, 0.21 mmol), and
DMAP (3 mg, 21 mmol) in pyridine (1 mL) was stirred at
room temperature. After two days, the mixture was parti-
tioned between EtOAc and H2O. The organic layer was
washed with aqueous NaHCO3 (saturated) and brine, dried
(Na2SO4), and evaporated under reduced pressure. The resi-
due was puri®ed by column chromatography (SiO2, 2±10%
MeOH in CHCl3) to give 9a (63 mg, 98% as a white foam):
FAB-MS m/z 925 (M1); 1H NMR (400 MHz, CDCl3) d 7.86
(s, 1H), 7.38±6.80 (m, 13H), 6.27 (m, 1H), 6.17 (m, 1H),
5.48 (m, 1H), 3.76 (s, 6H), 3.23 (m, 3H), 3.11 (m, 1H), 2.60
(m, 4H), 2.48 (m, 1H), 2.41 (m, 1H), 2.10 (m, 2H), 1.91 (m,
1H), 1.79 (m, 1H), 1.53 (m, 2H), 1.43 (s, 3H), 1.24 (m,
24H), 0.88 (t, J7.1 Hz, 3H). HRMS (FAB) calcd for
C53H71O11N3 (M1): 925.5089. Found: 925.5060.
30-O-(tert-Butyldimethylsilyl)-50-O-(dimethoxytrityl)-40-
C-[N-(cholesteryloxycarbonyl)aminoethyl]thymidine (7c).
A mixture of cholesterol (165 mg, 0.43 mmol) and N,N0-
carbonyldiimidazole (69 mg, 0.43 mmol) in CH2Cl2
(3 mL) was stirred at room temperature. After 1 h, 6
(150 mg, 0.21 mmol) was added to the mixture, and the
whole was stirred at room temperature. After two days,
the mixture was concentrated in vacuo. The residue was
puri®ed by column chromatography (SiO2, 25±40%
EtOAc in hexane) to give 7c (162 mg, 70% as a white
1
foam): FAB-MS m/z 1136 (MNa1); H NMR (400 MHz,
CDCl3) d 8.09 (s, 1H), 7.57 (s, 1H), 7.42±6.82 (m, 13H),
6.23 (t, J6.6 Hz, 1H), 5.35 (m, 1H), 4.84 (m, 1H), 4.57 (dd,
J6.4, 4.4 Hz, 1H), 4.45 (m, 1H), 3.79 (s, 6H), 3.34 (d,
J10.0 Hz, 1H), 3.20 (m, 2H), 3.11 (d, J10.0 Hz, 1H),
2.30 (m, 2H), 1.88 (m, 1H), 1.65 (m, 1H), 2.24±0.67 (m,
53H), 0.04 (s, 3H), 20.03 (s, 3H). HRMS (FAB) calcd for
C67H95O9N3SiNa (MNa1): 1136.6736. Found: 1136.6750.
50-O-(Dimethoxytrityl)-40-C-[N-(oleoyl)aminoethyl]-30-
O-(succinyl)thymidine (9b). Compound 8b (64 mg;
75 mmol) was succinylated as described in the preparation
of 9a to give 9b (59 mg, 83% as a white foam): FAB-MS
m/z 951 (M1); 1H NMR (400 MHz, CDCl3) d 7.47 (s, 1H),
7.38±6.81 (m, 13H), 6.29 (m, 1H), 6.06 (m, 1H), 5.53 (m,
1H), 5.33 (m, 2H), 3.78 (s, 6H), 3.25 (m, 3H), 3.14 (m, 1H),
2.64 (m, 4H), 2.49 (m, 1H), 2.41 (m, 1H), 2.10 (m, 2H), 1.99
(m, 4H), 1.90 (m, 1H), 1.71 (m, 1H), 1.54 (m, 2H), 1.42 (s,
3H), 1.26 (m, 20H), 0.87 (t, J6.6 Hz, 3H). HRMS (FAB)
calcd for C55H73O11N3 (M1): 951.5245. Found: 951.5232.
50-O-(Dimethoxytrityl)-40-C-[N-(palmitoyl)aminoethyl]-
thymidine (8a). A mixture of 7a (88 mg, 90 mmol) and
TBAF (1 M in THF, 0.19 mL, 0.19 mmol) in THF (1 mL)
was stirred at room temperature. After 30 min, the mixture
was concentrated in vacuo. The residue was puri®ed by
column chromatography (SiO2, 60±100% EtOAc in hexane)
to give 8a (70 mg, 94% as a white foam): FAB-MS m/z 825
1
(M1); H NMR (400 MHz, CDCl3) d 8.29 (s, 1H), 7.52 (s,
1H), 7.40±6.82 (m, 13H), 6.37 (t, J6.6 Hz, 1H), 5.89 (t,
J5.4 Hz, 1H), 4.52 (m, 1H), 3.95 (d, J3.17 Hz, 1H), 3.80
(s, 6H), 3.27 (m, 1H), 3.24 (d, J10.3 Hz, 1H), 3.19 (d,
J10.3 Hz, 1H), 3.00 (m, 1H), 2.40 (m, 2H), 2.12 (t,
J7.3 Hz, 1H), 1.91 (m, 2H), 1.64 (m, 2H), 1.56 (m, 2H),
1.50 (s, 3H), 1.25 (m, 22H), 0.88 (t, J7.1 Hz, 3H). HRMS
(FAB) calcd for C49H67O8N3: 825.4928 (M1). Found:
825.4948. Anal. Calcd for C49H67O8N3: C, 71.24; H, 8.17;
N, 5.09. Found: C, 71.21; H, 8.22; N, 5.06.
50-O-(Dimethoxytrityl)-40-C-[N-(cholesteryloxycarbonyl)-
aminoethyl]-30-O-(succinyl)thymidine (9c). Compound 8c
(64 mg, 75 mmol) was succinylated as described in the
preparation of 9a to give 9c (86 mg, 97% as a white
1
foam): FAB-MS m/z 1100 (MH1); H NMR (400 MHz,
CDCl3) d 8.62 (s, 1H), 7.94 (s, 1H), 7.38±6.81 (m, 13H),
6.27 (m, 1H), 5.94 (m, 1H), 5.33 (m, 1H), 4.42 (m, 1H), 3.77
(s, 6H), 3.25 (m, 3H), 3.10 (m, 2H), 2.62 (m, 2H), 2.41 (m,
2H), 1.87 (m, 2H), 1.83 (m, 1H), 2.31±0.67 (m, 44H).
HRMS (FAB) calcd for C65H86O12N3 (MH1): 1100.6211.
Found: 1100.6230.
50-O-(Dimethoxytrityl)-40-C-[N-(oleoyl)aminoethyl]thymi-
dine (8b). Compound 7b (96 mg, 0.10 mmol) was de-silyl-
ated as described in the preparation of 8a to give 8b (75 mg,
1
88% as a white foam): FAB-MS m/z 851 (M1); H NMR
(400 MHz, CDCl3) d 8.18 (s, 1H), 7.47 (s, 1H), 7.40±6.82
(m, 13H), 6.37 (t, J6.6 Hz, 1H), 5.87 (dd, J5.9, 5.4 Hz,
1H), 5.34 (m, 2H), 4.52 (m, 1H), 3.89 (m, 1H), 3.79 (s, 6H),
3.25 (m, 1H), 3.24 (d, J10.0 Hz, 1H), 3.19 (d, J10.0 Hz,
1H), 2.99 (m, 1H), 2.40 (m, 2H), 2.12 (t, J7.3 Hz, 2H),
1.99 (m, 4H), 1.89 (m, 2H), 1.58 (m, 4H), 1.51 (s, 3H), 1.27
(m, 18H), 0.88 (t, J7.1 Hz, 3H). HRMS (FAB) calcd for
C51H69O8N3: 851.5085 (M1). Found: 851.5100. Anal. Calcd
for C51H69O8N3Si´1/4H2O: C, 71.51; H, 8.22; N, 4.84.
Found: C, 71.52; H, 8.22; N, 4.91.
Synthesis of the controlled pore glass support with 9a, 9b
or 9c
Aminopropyl controlled pore glass (158 mg, 14.2 mmol,
89.8 mmol/g, CPG Inc.) was added to a solution of 9a
(53 mg, 57 mmol) and WSCI (11 mg, 57 mmol) in DMF
(1 mL), and the mixture was kept at room temperature for
two days. After the resin was washed with pyridine, 1 mL of
a capping solution (0.1 M DMAP in pyridine/Ac2O9:1)
was added, and the whole was kept at room temperature